Physician profile
Adam Eric Berman
NPI 1588613194
$16,324.47
in general payments reported to CMS, 2019-2025
34 companies · $2,045 in 2025
The $2,045 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2020: $1,403 · 2021: $968 · 2022: $1,155 · 2023: $4,212 · 2024: $5,531 · 2025: $2,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,796 · Travel and Lodging: $4,866 · Education: $98.16 · Entertainment: $27.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,796.04 |
| Travel and Lodging | $4,866.25 |
| Education | $98.16 |
| Entertainment | $27.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,111.20 | 2019-2025 | Farapulse, Rhythmia Mapping System, Watchman Access System |
| Biosense Webster, INC. | $5,508.92 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Abbott Laboratories | $931.49 | 2019-2025 | Aveir, Gallant, Ensite |
| Medtronic, INC. | $456.32 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abiomed | $235.41 | 2022-2024 | Impella |
| Merck Sharp & Dohme LLC | $222.22 | 2022-2025 | Verquvo, Keytruda |
| Atricure, INC. | $208.52 | 2019-2024 | |
| Pfizer INC. | $173.17 | 2019-2025 | |
| Medical Device Business Services, INC. | $158.28 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.45 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $139.31 | 2023 | Magnetom Altea |
| Medtronic Vascular, INC. | $125.61 | 2019-2020 | |
| Inspire Medical Systems, INC. | $118.85 | 2024 | Inspire |
| Impulse Dynamics (USA) INC. | $108.95 | 2023-2025 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $89.03 | 2022-2024 | Xarelto |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stereotaxis INC | $66.97 | 2019-2024 | Genesis |
| Amgen INC. | $60.17 | 2021-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $54.75 | 2023-2024 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.83 | 2022 | |
| Bardy Diagnostics, INC. | $45.00 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $36.64 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $33.79 | 2022-2025 | Amvuttra |
| Cvrx, INC. | $27.01 | 2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $26.53 | 2022 | |
| Cardiva Medical, INC. | $26.21 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Ge Healthcare | $25.67 | 2021 | |
| Biotronik INC. | $24.27 | 2020 | |
| Teleflex LLC | $19.48 | 2022 | |
| Daiichi Sankyo INC. | $18.85 | 2024 | Injectafer |
| Terumo Medical Corporation | $17.85 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $16.53 | 2024 | |
| Bridgebio Pharma, INC. | $16.35 | 2025 | Attruby |
| Novartis Pharmaceuticals Corporation | $13.84 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.